ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, providing promising breakthroughs across numerous health-related and industrial purposes. With its structural similarity to In a natural way derived human serum albumin, OsrHSA presents a safer, extra responsible alternative for the